نتائج البحث - Pierre Feugier

تنقيح النتائج
  1. 1
    Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity

    Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity حسب Na Li, Pierre Feugier, Brigitte Serrurrier, Véronique Latger‐Cannard, Jean‐François Lesesve, Jean‐François Stoltz, Assia Eljaafari

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Impact of Rituximab and/or High-Dose Therapy With Autotransplant at Time of Relapse in Patients With Follicular Lymphoma: A GELA Study

    Impact of Rituximab and/or High-Dose Therapy With Autotransplant at Time of Relapse in Patients With Follicular Lymphoma: A GELA Study حسب Catherine Sebban, Pauline Brice, Richard Delarue, Corinne Haïoun, Bertrand Souleau, Nicolas Mounier, Nicole Brousse, Pierre Feugier, Hervé Tilly, Philippe Solal‐Céligny, Bertrand Coiffier

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)

    Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CL... حسب Anne Quinquenel, Christophe Willekens, Jehan Dupuis, Bruno Royer, Loïc Ysebaert, Sophie de Guibert, Anne‐Sophie Michallet, Pierre Feugier, Romain Guièze, Vincent Lévy, Alain Delmer

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

    Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymp... حسب Catherine Sebban, Nicolas Mounier, Nicole Brousse, Coralie Bélanger, Pauline Brice, Corinne Haïoun, Hervé Tilly, Pierre Feugier, R. Bouabdallah, Chantal Doyen, Gilles Salles, Bertrand Coiffier

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia

    Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia حسب Édouard Cornet, Alain Delmer, Pierre Feugier, Francine Garnache‐Ottou, David Ghez, Véronique Leblond, Vincent Lévy, Frédéric Maloisel, Daniel Re, Jean‐Marc Zini, Xavier Troussard

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Incidence and risk factors for central nervous system occurrencein elderly patients with diffuse large-B-cell lymphoma: influenceof rituximab

    Incidence and risk factors for central nervous system occurrencein elderly patients with diffuse large-B-cell lymphoma: influenceof rituximab حسب Pierre Feugier, J.-M. Virion, Hervé Tilly, Corinne Haïoun, Gérald Marit, Margaret Macro, Dominique Bordessoule, Christian Récher, Michel Blanc, Thierry Jo Molina, P Lederlin, Bertrand Coiffier

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report

    Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report حسب Mira Tout, Olivier Casasnovas, Michel Meignan, T. Lamy, Franck Morschhauser, Gilles Salles, Emmanuel Gyan, Corinne Haïoun, Mélanie Mercier, Pierre Feugier, Sami Boussetta, Gilles Paintaud, David Ternant, Guillaume Cartron

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study

    Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study حسب Franck Morschhauser, Guillaume Cartron, Catherine Thiéblemont, Philippe Solal‐Céligny, Corinne Haïoun, Réda Bouabdallah, Pierre Feugier, Krimo Bouabdallah, Elina Asikanius, Guiyuan Lei, Michael Wenger, Elisabeth Wassner-Fritsch, Gilles Salles

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Primary Lymphoma of the Liver: Clinical–Pathological Features and Relationship With Hcv Infection in French Patients

    Primary Lymphoma of the Liver: Clinical–Pathological Features and Relationship With Hcv Infection in French Patients حسب Jean‐Pierre Bronowicki, Catherine Bineau, Pierre Feugier, Olivier Hermine, Nicole Brousse, Frédéric Oberti, Marie-Christine Rousselet, Sébastien Dharancy, Philippe Gaulard, Jean–François Fléjou, Dominique Cazals–Hatem, Eric Labouyrie

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

    Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients حسب M Leporrier, Sylvie Chevret, Bruno Cazin, Najda Boudjerra, Pierre Feugier, B Desablens, Marie‐José Rapp, J. Jaubert, Claudie Autrand, Marine Diviné, Brigitte Dreyfus, Karim Maloum, Philippe Travade, Guillaume Dighiero, Jacques‐Louis Binet, Claude Chastang

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

    Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte حسب Pierre Feugier, Ambro van Hoof, Catherine Sebban, P. Solal-Céligny, Réda Bouabdallah, Christophe Fermé, B. Christian, Éric Lepage, Hervé Tilly, Franck Morschhauser, Philippe Gaulard, Gilles Salles, André Bosly, Christian Gisselbrecht, F Reyes, Bertrand Coiffier

    منشور في 2005
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

    High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma حسب Marie‐Hélène Delfau‐Larue, Wolfram Klapper, Françoise Berger, Fabrice Jardin, Josette Brière, Gilles Salles, Olivier Casasnovas, Pierre Feugier, Corinne Haïoun, Vincent Ribrag, Catherine Thiéblemont, Michael Unterhalt, Martin Dreyling, Elizabeth Macintyre, Christiane Pott, Olivier Hermine, Eva Hoster

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study

    Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study حسب Fabrice Jardin, Jean‐Philippe Jaïs, Thierry Jo Molina, Françoise Parmentier, Jean‐Michel Picquenot, Philippe Ruminy, Hervé Tilly, Christian Bastard, Gilles Salles, Pierre Feugier, Catherine Thiéblemont, Christian Gisselbrecht, Aurélien de Reyniès, Bertrand Coiffier, Corinne Haïoun, Karen Leroy

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab

    The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituxima... حسب JP Jais, Corinne Haïoun, Thierry Jo Molina, David S. Rickman, Aurélien de Reyniès, F Berger, Christian Gisselbrecht, Josette Brière, F Reyes, Philippe Gaulard, Pierre Feugier, Eric Labouyrie, Hervé Tilly, Christian Bastard, Bertrand Coiffier, Gilles Salles, Karen Leroy

    منشور في 2008
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study

    Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study حسب Gilles Salles, Nicolas Mounier, Sophie de Guibert, Franck Morschhauser, Chantal Doyen, Jean‐François Rossi, Corinne Haïoun, Pauline Brice, Beatrice Mahé, Réda Bouabdallah, B. Audhuy, Christophe Fermé, Caroline Dartigeas, Pierre Feugier, Catherine Sebban, Luc Xerri, Charles Foussard

    منشور في 2008
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2–3 diffuse large B-cell lymphoma

    Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2–3 diffuse large B-cell lymphoma حسب Anne Plonquet, Corinne Haïoun, J.P. Jais, A. Debard, Gilles Salles, Marie C. Béné, Pierre Feugier, C. Rabian, Olivier Casasnovas, Myriam Labalette, Emilienne Kühlein, J P Farcet, Jean‐François Emile, C Gisselbrecht, Marie‐Hélène Delfau‐Larue

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

    Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome حسب Bruno Chetaille, François Bertucci, Pascal Finetti, Benjamin Esterni, Aspasia Stamatoullas, Jean Michel Picquenot, M.C. Copin, F. Morschhauser, Olivier Casasnovas, Tony Petrella, Thierry Jo Molina, Anne Vekhoff, Pierre Feugier, Réda Bouabdallah, Daniel Birnbaum, Daniel Olive, Luc Xerri

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma

    Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma حسب Emmanuel Bachy, Roch Houot, F. Morschhauser, Anne Sonet, Pauline Brice, Karim Belhadj, Guillaume Cartron, B. Audhuy, Christophe Fermé, Pierre Feugier, Catherine Sebban, Vincent Delwail, Hervé Maisonneuve, Steven Le Gouill, Sophie Lefort, Nicole Brousse, C. Foussard, Gilles Salles

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Immuno–Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study

    Immuno–Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study حسب Christiane Copie‐Bergman, Philippe Gaulard, Karen Leroy, Josette Brière, Maryse Baia, Jean‐Philippe Jaïs, Gilles Salles, Françoise Berger, Corinne Haïoun, Hervé Tilly, Jean‐François Emile, Alison H. Banham, Nicolas Mounier, Christian Gisselbrecht, Pierre Feugier, Bertrand Coiffier, Thierry Jo Molina

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation

    Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation حسب Simona Pagliuca, Carmelo Gurnari, Colin Hercus, Sébastien Hergalant, Sanghee Hong, Adèle Dhuyser, Maud D’Aveni, Alice Aarnink, Marie Thérèse Rubio, Pierre Feugier, Francesca Ferraro, Hetty E. Carraway, Ronald Sobecks, Betty K. Hamilton, Navneet S. Majhail, Valeria Visconte, Jaroslaw P. Maciejewski

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: